4-氯-N-羟基苯羧酰亚胺 | 5033-28-3

• 物质功能分类: 有机原料 - 氨基化合物
• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 4-氯-N-羟基苯羧酰亚胺
• 英文名称: 4-chlorobenzamidoxime
• 英文别名: 4-chloro-N'-hydroxybenzimidamide；p-chlorobenzamidoxime；4-chloro-N'-hydroxybenzamidine；4-chloro-N'-hydroxybenzenecarboximidamide；4-chlorobenzamide oxime；4-chloro-N’-hydroxybenzimidamide；4-chloro-N’-hydroxybenzamidine
• CAS: 5033-28-3
• 化学式: C₇H₇ClN₂O
• mdl: MFCD00464111
• 分子量: 170.598
• InChiKey: QBGONPQFBDUVPG-UHFFFAOYSA-N

物化性质

• 熔点：
  131 °C
• 沸点：
  274.9±42.0 °C(Predicted)
• 密度：
  1.36±0.1 g/cm3(Predicted)
• 溶解度：
  可溶于DMSO（少许）、甲醇（少许）

计算性质

• 辛醇/水分配系数(LogP)：
  1.7
• 重原子数：
  11
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  58.6
• 氢给体数：
  2
• 氢受体数：
  2

安全信息

• 危险等级：
  IRRITANT
• 危险品标志：
  Xi
• 安全说明：
  S26,S37/39
• 危险类别码：
  R36/37/38
• 海关编码：
  2925290090
• 储存条件：
  存储条件：2-8°C，需密封并保持干燥。

SDS

Name:	4-Chloro-N -hydroxybenzenecarboximidamide 95+% Material Safety Data Sheet
Synonym:	4-Chlorobenzamide oxim
CAS:	5033-28-3

Section 1 - Chemical Product MSDS Name:4-Chloro-N -hydroxybenzenecarboximidamide 95+% Material Safety Data Sheet
Synonym:4-Chlorobenzamide oxim

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
5033-28-3	4-Chloro-N'-hydroxybenzenecarboximidam	95+%	unlisted

Hazard Symbols: XI
Risk Phrases: 36/37/38

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Irritating to eyes, respiratory system and skin.
Potential Health Effects
Eye:
Causes eye irritation.
Skin:
Causes skin irritation. May be harmful if absorbed through the skin.
Ingestion:
May cause irritation of the digestive tract. May be harmful if swallowed.
Inhalation:
Causes respiratory tract irritation. May be harmful if inhaled.
Chronic:
Not available.

---

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Get medical aid. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:
Treat symptomatically and supportively.

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container.

---

Section 7 - HANDLING and STORAGE
Handling:
Avoid breathing dust, vapor, mist, or gas. Avoid contact with skin and eyes.
Storage:
Store in a cool, dry place. Store in a tightly closed container.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 5033-28-3: Personal Protective Equipment Eyes: Not available.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid
Color: off-white
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 129 - 132 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C7H7ClN2O
Molecular Weight: 171

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Not available.
Conditions to Avoid:
Incompatible materials.
Incompatibilities with Other Materials:
Oxidizing agents, bases, acids.
Hazardous Decomposition Products:
Hydrogen chloride, chlorine, nitrogen oxides, carbon monoxide, carbon dioxide.
Hazardous Polymerization: Has not been reported

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 5033-28-3 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
4-Chloro-N'-hydroxybenzenecarboximidamide - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
No information available.
IMO
No information available.
RID/ADR
No information available.

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XI
Risk Phrases:
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 37/39 Wear suitable gloves and eye/face
protection.
WGK (Water Danger/Protection)
CAS# 5033-28-3: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 5033-28-3 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 5033-28-3 is not listed on the TSCA inventory.
It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  4-氯-N-羟基苯羧酰亚胺 在 palladium on activated charcoal 甲酸铵 作用下， 以 溶剂黄146 为溶剂， 反应 3.0h， 以77%的产率得到苯甲脒
  参考文献：
  名称：

  Direct Conversion of Amidoximes to Amidines via Transfer Hydrogenation

  摘要：

  阿米度肟、O-烷基阿米度肟和O-酰基阿米度肟可通过与甲酸铵和Pd/C在醋酸中反应，直接转化为腙。

  DOI：

  10.1055/s-2003-42410
• 作为产物：
  描述：

  Alpha,4-二氯苯甲醛肟 在 氨 作用下， 以 乙醇 为溶剂， 生成 4-氯-N-羟基苯羧酰亚胺
  参考文献：
  名称：

  α-氯醛肟、醛肟和酰胺肟的磺酸酯通过“亚砜”加成

  摘要：

  在三乙胺的存在下，芳族腈氧化物与甲磺酰氯和苄基磺酰氯反应生成 α-氯醛肟的磺酸酯。在相同的反应条件下...

  DOI：

  10.1139/v66-041

文献信息

• Cobalt-Catalyzed Electrophilic Cyanation of Arylzinc Halides with<i>N</i>-Cyano-<i>N</i>-phenyl-<i>p</i>-methylbenzenesulfonamide (NCTS)
  作者：Yingxiao Cai、Xin Qian、Alice Rérat、Audrey Auffrant、Corinne Gosmini

  DOI：10.1002/adsc.201500245

  日期：2015.11.16

  The cobalt-catalyzed cross-coupling of organozinc bromides with N-cyano-N-phenyl-p-methylbenzenesulfonamide (NCTS) is described. The same cobalt catalyst, cobalt(II) bromide, was used for both the synthesis of the organozinc species and the cross-coupling reaction. However in this case, a catalytic amount of zinc dust is necessary in the second step to release the low-valent cobalt. Under these mild

  描述了有机锌溴化物与N-氰基-N-苯基-对甲基苯磺酰胺（NCTS）的钴催化交叉偶联。相同的钴催化剂溴化钴（II）用于有机锌物质的合成和交叉偶联反应。然而，在这种情况下，在第二步骤中需要催化量的锌粉以释放低价钴。在这些温和的条件下，获得了中等至极好的不同苄腈的收率。
• Substituted 3-aryl-5-aryl-[1,2,4]-oxadiazoles and analogs as activators of caspases and inducers of apoptosis and the use thereof
  申请人：——

  公开号：US20030045546A1

  公开（公告）日：2003-03-06

  The present invention is directed to substituted 3-aryl-5-aryl-[1,2,4]-oxadiazoles and analogs thereof, represented by the Formula I: 1 wherein Ar 1 , Ar 3 , A, B and D are defined herein. The present invention also relates to the discovery that compounds having Formula I are activators of caspases and inducers of apoptosis. Therefore, the activators of caspases and inducers of apoptosis of this invention may be used to induce cell death in a variety of clinical conditions in which uncontrolled growth and spread of abnormal cells occurs.

  本发明涉及取代的3-芳基-5-芳基-[1,2,4]-噁二唑及其类似物，由以下式I表示： 1 其中Ar1，Ar3，A，B和D在此处定义。本发明还涉及发现具有式I的化合物是caspase的激活剂和凋亡诱导剂。因此，本发明的caspase激活剂和凋亡诱导剂可用于诱导在各种临床病况中发生未受控制的异常细胞生长和扩散的细胞死亡。
• [EN] 3-PYRIMIDIN-4-YL-OXAZOLIDIN-2-ONES AS INHIBITORS OF MUTANT IDH<br/>[FR] 3-PYRIMIDIN-4-YL-OXAZOLIDIN-2-ONES COMME INHIBITEURS D'IDH MUTANTE
  申请人：NOVARTIS AG

  公开号：WO2014141104A1

  公开（公告）日：2014-09-18

  The invention is directed to a formula (I), or a pharmamceutically acceptable salt thereof, wherein R1, R2a, R2b and R3-R7 are herein. The invention is also directed to compositions containing a compound of formula (I) and to the use of such compounds in the inhibition of mutant IDH proteins having a neomorphic activity. The invention is further directed to the use of a compound of formula (I) in the treatment of diseases or disorders associated with such mutant IDH proteins including, but not limited to, cell-proliferation disorders, such as cancer.

  这项发明涉及一种式(I)的配方，或其药用可接受的盐，其中R1、R2a、R2b和R3-R7在此处。该发明还涉及含有式(I)化合物的组合物，以及在抑制具有新型活性的突变IDH蛋白中使用这种化合物的用途。该发明还涉及在治疗与这种突变IDH蛋白相关的疾病或紊乱中使用式(I)化合物，包括但不限于细胞增殖紊乱，如癌症。
• Design, synthesis and biological activities of piperidine-spirooxadiazole derivatives as α7 nicotinic receptor antagonists
  作者：Han Zhang、Xiaomeng He、Xintong Wang、Bo Yu、Siqi Zhao、Peili Jiao、Hongwei Jin、Zhenming Liu、KeWei Wang、Liangren Zhang、Lihe Zhang

  DOI：10.1016/j.ejmech.2020.112774

  日期：2020.12

  identified a piperidine-spirooxadiazole derivative T761–0184 that acts as a α7 antagonist. A series of novel piperidine-spirooxadiazole derivatives were subsequently synthesized and evaluated using two-electrode voltage clamp (TEVC) assay in Xenopus oocytes. Lead compounds from two series inhibited α7 with their IC50 values ranging from 3.3 μM to 13.7 μM. Compound B10 exhibited α7 selectivity over other α4β2

  α 已经提出在神经和免疫系统中表达的7种烟碱乙酰胆碱受体（nAChRs）在炎症控制中起重要作用。然而，由于缺乏的拮抗剂工具特异性抑制α 7个的nAChR阻碍通道作为治疗靶的验证。要发现的选择性α 7拮抗剂，我们开始了基于药效的虚拟筛选和鉴定的哌啶衍生物spirooxadiazole T761 - 0184充当α 7拮抗剂。随后在非洲爪蟾卵母细胞中合成了一系列新型哌啶-螺二恶唑衍生物，并使用两电极电压钳（TEVC）分析对其进行了评估。两个系列的铅化合物均受抑制α7的IC 50值为3.3μM至13.7μM。化合物B10表现出α 7选择性超过其它α 4 β 2和α 3 β 4的nAChR亚型。的结构-活性关系的分析（SAR）提供了一种用于选择性的进一步发展了有价值的见解α 7的nAChR拮抗剂。
• Imidazole hydrochloride promoted synthesis of 3,5-disubstituted-1,2,4-oxadiazoles
  作者：Xuetong Wang、Yin Wang、Xiaoling Liu、Tingshu He、Lingli Li、Huili Wu、Shangjun Zhou、Dan Li、Siwei Liao、Ping Xu、Xing Huang、Jianyong Yuan

  DOI：10.1016/j.tet.2021.132496

  日期：2021.11

  Imidazole hydrochloride as an additive promotes the reaction of amidoximes and DMA derivatives to generated 3,5-disubstituted-1,2,4-oxadiazoles in low to excellent yields without the use of coupling reagents, oxidants, strong acids or bases and other additives.

  咪唑盐酸盐作为添加剂促进酰胺肟和 DMA 衍生物反应生成 3,5-二取代-1,2,4-恶二唑，收率从低到高，无需使用偶联剂、氧化剂、强酸或强碱和其他添加剂。

表征谱图